BSGSX
Price
$17.15
Change
-$0.28 (-1.61%)
Updated
Nov 14 closing price
PMAQX
Price
$47.96
Change
-$0.50 (-1.03%)
Updated
Nov 14 closing price
Ad is loading...

BSGSX vs PMAQX

Header iconBSGSX vs PMAQX Comparison
Open Charts BSGSX vs PMAQXBanner chart's image
Baird Small/Mid Cap Growth Investor
Price$17.15
Change-$0.28 (-1.61%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$47.96
Change-$0.50 (-1.03%)
VolumeN/A
CapitalizationN/A
BSGSX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BSGSX vs. PMAQX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSGSX is a StrongBuy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30B vs. BSGSX (196M). PMAQX pays higher dividends than BSGSX: PMAQX (0.10) vs BSGSX (0.00). BSGSX was incepted earlier than PMAQX: BSGSX (6 years) vs PMAQX (8 years). BSGSX is a more actively managed with annual turnover of: 48.00 vs. PMAQX (10.10). PMAQX has a lower initial minimum investment than BSGSX: PMAQX (0) vs BSGSX (2500). PMAQX annual gain was more profitable for investors over the last year : 31.19 vs. BSGSX (18.11). PMAQX return over 5 years is better than : 53.50 vs. BSGSX (44.73).
BSGSXPMAQXBSGSX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years8 years-
Gain YTD8.88925.09135%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets196M30B1%
Annual Yield % from dividends0.000.10-
Returns for 1 year18.1131.1958%
Returns for 3 years-19.785.78-342%
Returns for 5 years44.7353.5084%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBY0.730.01
+2.04%
NovaBay Pharmaceuticals
THCH0.70N/A
+0.20%
TH International Limited
REAX5.17-0.09
-1.71%
Real Brokerage (The)
TNDM28.59-1.08
-3.64%
Tandem Diabetes Care
NIO4.43-0.18
-3.90%
NIO Inc.